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Abstract: Semliki Forest virus (SFV) is an arthropod-borne alphavirus that induces membrane 
invaginations (spherules) in host cells. These harbor the viral replication complexes (RC) that 
synthesize viral RNA. Alphaviruses have four replicase or nonstructural proteins (nsPs), nsP1–4, 
expressed as polyprotein P1234. An early RC, which synthesizes minus-strand RNA, is formed by 
the polyprotein P123 and the polymerase nsP4. Further proteolytic cleavage results in a late RC 
consisting of nsP1–4 and synthesizing plus strands. Here, we show that only the late RCs are highly 
active in RNA synthesis in vitro. Furthermore, we demonstrate that active RCs can be isolated from 
both virus-infected cells and cells transfected with the wild-type replicase in combination with a 
plasmid expressing a template RNA. When an uncleavable polyprotein P123 and polymerase nsP4 
were expressed together with a template, high levels of minus-strand RNA were produced in cells, 
but RCs isolated from these cells were hardly active in vitro. Furthermore, we observed that the 
uncleavable polyprotein P123 and polymerase nsP4, which have previously been shown to form 
spherules even in the absence of the template, did not replicate an exogenous template. 
Consequently, we hypothesize that the replicase proteins were sequestered in spherules and were 
no longer able to recruit a template. 
Keywords: alphavirus; Semliki Forest virus; nonstructural protein; polymerase; replication 
complex; in vitro replication; RNA synthesis 
 
1. Introduction 
Positive-strand RNA (+RNA) viruses are the most common type of RNA viruses, and include 
numerous human pathogens [1]. The recent re-emergence and outbreaks of chikungunya virus 
(CHIKV) highlight the medical significance of alphaviruses, which belong to the alphavirus-like 
superfamily containing several families of +RNA viruses from animals or plants [2–4]. Alphaviruses 
form the family Togaviridae together with the rubella virus, and they are mainly arthropod-borne 
viruses that infect vertebrates. The alphavirus genome of about 11–12 kb contains a 5′ cap and 
encodes two polyproteins. The P1234 polyprotein is processed into four nonstructural proteins 
(nsPs), nsP1–4, and the structural polyprotein, translated from a subgenomic RNA, is cleaved to 
yield the capsid and envelope proteins [5]. All four nsPs are required for viral RNA synthesis [6–8], 
and they form a membrane-associated replication complex (RC). nsP1 is the RNA-capping enzyme 
and the only viral protein responsible for anchoring the RC to membranes; nsP2 is the helicase and 
protease; nsP3 interacts with several host factors; and nsP4 is the core RNA-dependent RNA 
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polymerase [9–16]. All members of the alphavirus-like superfamily share capping, helicase, and 
polymerase domains in their replicase proteins [2]. 
Membrane-associated RCs are typical of all eukaryotic +RNA viruses. Membrane connection is 
indispensable, and two types of replication-associated membrane modifications have been 
recognized: membrane invaginations called spherules, as e.g., induced by alphaviruses; and 
double-membrane vesicles (DMVs), as e.g., induced by coronaviruses [17]. Alphaviruses form 
spherules at the plasma membrane, and CHIKV and Sindbis virus (SINV) spherules predominantly 
stay at the plasma membrane, while Semliki Forest virus (SFV) spherules are internalized to endo- 
and lysosomal membranes [18–20]. 
The early RCs of alphaviruses are formed when the polymerase nsP4 is first cleaved from the 
nonstructural polyprotein. The resulting complex of P123 and nsP4 mainly synthesizes 
minus-strand RNA using the genomic RNA as a template [8,21]. Next, P123 is cleaved to individual 
proteins, and the fully processed nsPs form the late RC, which synthesizes only genomic and 
subgenomic plus strands from the minus-strand RNA [8]. It has been shown that the template’s 
length determines SFV spherule size [22], and the current view is that the minus-strand RNA 
synthesized from the genomic template is inside the mature spherule as part of double-stranded 
RNA (dsRNA) molecules that form the replicative intermediates, and newly made plus strands are 
released into the cytoplasm [23–25]. 
Plasmid-based trans-replication systems have been developed to study the formation and 
activity of alphaviral RCs and the functions of the nsPs outside the context of viral infection 
[19,22,24,26–29]. The replicase proteins are expressed from one or several plasmids together with a 
separate plasmid that expresses a template RNA that can be replicated in trans. However, active 
replication is achieved only when plus-stranded RNA is expressed as a template. This indicates that 
replication cannot initiate from a single-stranded minus strand as a template, but rather requires a 
dsRNA intermediate for plus-strand synthesis [27,30]. Furthermore, it has been recently shown that 
a partially uncleaved alphavirus replicase can form spherules in the absence of the RNA template 
[29]. The template-independent spherule formation requires a combination of the uncleaved P123 
and nsP4 or nsP1, or uncleaved P23 and nsP4. Furthermore, even a polymerase mutant (nsP4GAA) 
with its active site Gly-Asp-Asp (GDD) mutated to Gly-Ala-Ala (GAA) causes spherule formation 
when co-expressed with P123 or nsP1 and P23. Spherule morphology in the absence of the template 
is, however, more irregular compared to those formed during normal replication, confirming the 
idea that the template plays a central role in size determination. 
The RNA-synthesizing activity of alphavirus RCs has also been studied using in vitro 
replication assays (IVRAs). CHIKV, SINV, and SFV synthesize single-stranded genomic and 
subgenomic RNA as well as double-stranded RNA in vitro [25,31,32], and for CHIKV it has been 
shown that in vitro any produced RNA is of positive polarity [25]. Besides genomic and subgenomic 
RNA, CHIKV and other alphaviruses synthesize an RNA species of about 7.5 kb [25,33]. This RNA II 
contains the 5′ end of the genome up to the subgenomic promoter. Although RNA II is produced 
both in cells and in vitro, its function remains an unanswered question [25]. 
Here, we applied the IVRA developed for CHIKV [25] to study the RNA synthesis of SFV in the 
trans-replication system. With the assay, robust activity could be measured in samples prepared 
from SFV-infected cells. The subsequent in vitro characterization of RCs formed upon the expression 
of different SFV replicase constructs using the trans-replication system revealed that only the fully 
processed polyprotein supports highly active RNA synthesis. 
2. Materials and Methods 
2.1. Cell Culture, Plasmids, and Viruses 
BHK (baby hamster kidney)-21 cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM; Sigma-Aldrich, St. Louis, MS, United States) supplemented with 10% (v/v) fetal bovine 
serum (FBS; Gibco, Baltimore, MD, USA), 2 mM L-glutamine (Gibco), 100 U/mL penicillin (Gibco), 
and 100 µg/mL streptomycin (Gibco). BSR T7/5 cells, a derivative of BHK-21 cells stably expressing 
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T7 RNA polymerase [34], were maintained in DMEM supplemented with 10% FBS, 2% (v/v) Difco 
tryptose phosphate broth (Becton, Dickinson and Company, Franklin Lakes, NJ, USA), 2 mM 
L-glutamine, 1% (v/v) non-essential amino acids (Gibco), 1 mg/mL G418 (Merck, Kenilworth, NJ, 
USA), 100 U/mL penicillin, and 100 µg/mL streptomycin (Gibco). Both cell lines were grown at 37 °C 
and in 5% CO2. Virus-infected or transfected cells were grown in the same conditions. 
All virus and plasmid constructs used in this study contain a hemagglutinin (HA) peptide 
(YPYDVPDYA) in a frame within nsP3. For generation of SFV4-HA virus, the oligos encoding the 
HA-tag and flanking glycines were 5′-TCGAGGGCTACCCATACGATGTTCCAGATTACGCTG 
GTG-3′ and 5′-TCGACACCAGCGTAATCTGGAACATCGTATGGGTAGCCC-3′. Oligos were 
annealed, phosphorylated, and cloned into the XhoI site of replicon pSFV1-ZsG, removing the 
ZsGreen gene [18]. A larger piece containing the HA-insert was then transferred with SacI and NotI 
to pCMV-SFV4 [35]. The virus stocks were produced by transfecting ~3 × 106 BHK-21 cells with 2.5 
µg of pCMV-SFV4-HA using Lipofectamine LTX (Invitrogen, Carlsbad, CA, USA) according to the 
manufacturer’s instructions. After 16–18 h incubation in minimum essential medium (MEM; Gibco) 
containing 0.2% (v/v) bovine serum albumin (BSA) and 2 mM L-glutamine, the supernatant was 
collected. This primary stock was used to infect BHK-21 cells at a multiplicity of infection (MOI) of 
0.01 in MEM containing 0.2% BSA and 2 mM L-glutamine. After 1 h, cells were washed twice and 
new medium was added. The supernatant designated as secondary stock was collected after 16–18 h 
post infection (p.i.). Titers were quantified by plaque assay titration [36]. 
To generate HA-tagged replicase polyprotein constructs, the ZsGreen gene in constructs 
P123Z4 and P1^2^3Z4 [26] was replaced with an HA tag-containing Bsu36I-AgeI restriction 
fragment from the replicon. In order to obtain a P123HA4GAA expression construct, a NotI-BamHI 
fragment of nsP4 containing GAA substitution was transferred from P1234GAA [26] to P123HA4. For 
the construction of P12CA3HA, Bsu36I and AgeI were used to replace ZsGreen in P12CA3Z [24] with the 
HA-tag. The ubi-nsP4 and the template Tmed constructs have been described in [26]. 
2.2. Metabolic Labeling with 3H-Uridine 
BHK-21 cells were infected using the secondary stock of SFV4-HA at an MOI of 50 for 1 h in PBS 
containing 2% (v/v) fetal calf serum (FCS; Bodinco, Alkmaar, Netherlands). After the adsorption, 
cells were washed and DMEM containing 2% FCS was added. Mock-infected cells served as a 
control. Thirty minutes before labeling, cellular transcription was inhibited by adding Actinomycin 
D (5 µg/mL; Sigma-Aldrich). Metabolic pulse-labeling of approximately 6 × 105 mock- or 
SFV-infected cells was performed by incubating cells with 40 µCi of 3H-uridine (Perkin Elmer, Ayer 
Rajah, Singapore) in medium for 1 h. After the labeling, cells were lysed in LiDS/LET (5% lithium 
dodecyl sulfate, 20 mM Tris-HCl (pH 7.4), 100 mM LiCl, 2 mM EDTA, and 5 mM DTT) and treated 
with proteinase K (80 µg/mL; Thermo Fisher Scientific, Waltham, MA, USA) for 15 min at 42 °C. 
Total RNA was isolated using the acid phenol method and analysed by denaturing agarose gel 
electrophoresis as described below. Fluorographic detection of 3H-labeled RNA was performed as 
described in [37]. Incorporation of 3H-uridine was also quantified from 2-µL samples of isolated total 
RNA with a liquid scintillation counter (Beckman LS 6500 IC, Brea, CA, USA). 
2.3. Isolation of RCs from Infected or Transfected Cells 
For virus infection, the secondary stock of SFV4-HA was used to infect approximately 1 × 107 
BHK-21 cells at an MOI of 50 for 1 h in MEM containing 0.2% BSA and 2 mM L-glutamine. After the 
adsorption, cells were washed twice and new medium was added. Mock-infected cells served as a 
control. Cells were harvested by trypsinization at 4 h p.i., washed twice with phosphate-buffered 
saline, and resuspended in 0.5 mL of dilution buffer (DB) (35 mM HEPES (pH 7.4), 250 mM sucrose, 
2.5 mM DTT, 7 mM KCl) containing 2 µg/mL Actinomycin D, 200 U/mL RiboLock (Thermo Fisher 
Scientific), and Pierce EDTA-Free Protease Inhibitor (1 tablet per 10 mL; Thermo Fisher Scientific). 
After a 20-min incubation on ice, cells were disrupted using a Dounce homogenizer with 40 strokes 
and unlysed cells and nuclei were removed by centrifugation (510× g, 10 min, 4 °C) yielding a 
post-nuclear supernatant (PNS). A membrane pellet (P15) and cytosolic fraction (S15) were prepared 
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by further centrifugation of PNS (15,000× g, 10 min, 4 °C). The P15 fraction was washed once with DB 
containing Actinomycin D, RiboLock, and protease inhibitor and resuspended in the same buffer. 
For the trans-replication system, BSR cells were co-transfected with the replicase and Tmed 
template plasmids containing the T7 promoter [26]. LTX was used according to the manufacturer’s 
instructions. Per 10-cm dish containing approximately 4 × 106 cells, 5.5 µg of the replicase, and 6.9 µg 
of the template plasmid were co-transfected. Mock-transfected cells without LTX were used as a 
control. After a 16-h incubation in MEM containing 0.2% BSA and 2 mM L-glutamine, cells were 
harvested by trypsinization. PNS, P15, and S15 were prepared as described for virus infection. 
2.4. Purification of Membranes 
BSR cells were transfected with 12.4 µg of P1^2^3HA4 or P123HA4 plasmid DNA per 10-cm dish, 
cells were harvested at 6 or 16 h post transfection, and PNS was prepared as described above. 
HA-affinity capture was performed as described in [38], except that the elution was done by boiling 
the beads in Laemmli sample buffer. Membranes present in PNS samples were purified by flotation 
centrifugation (90,000× g, 18 h, 4 °C) in a discontinuous iodixanol (Sigma-Aldrich) gradient 
consisting of 1 mL DB, 9 mL 30% (w/v) iodixanol in DB, and 2 mL 35% iodixanol in DB. The final 
layer contained 0.5 mL PNS. Protease inhibitor was used throughout the purification. After the 
centrifugation, the light-scattering zone between DB and 30% iodixanol layers was collected and 
used for the Western blotting and replication assay described below. 
2.5. IVRA, RNA Isolation, Agarose Gel Electrophoresis, and in-Gel Hybridization 
IVRA was designed based on that described in [25]. Typically, 2-fold and 30-fold dilutions of 
PNS, P15, and S15 prepared from transfected and virus-infected cells were used, respectively. A 
standard 30-µL reaction contained 22 µL of PNS, P15, or S15, 1 mg/mL BSA, 28 mM HEPES (pH 7.4), 
200 mM sucrose, 2 mM DTT, 5.6 mM KCl, 3 mM magnesium acetate, 1.5 µg/mL Actinomycin D, 810 
U/mL RiboLock, 17 mM creatine phosphate (Sigma-Aldrich), 8.3 U/mL creatine phosphokinase 
(Sigma-Aldrich), 1 mM ATP, 10 µM UTP, 10 µM GTP, 8.5 µM CTP, and 0.055 µM (5 µCi) of 
α-32P-CTP (Perkin Elmer). For IVRA with exogenous template RNA, an in vitro transcript of Tmed 
was prepared using a SacI-linearized template plasmid and a mMESSAGE mMACHINE® T7 
Transcription Kit (Ambion, Thermo Fisher Scientific, Waltham, MA, USA) according to the 
manufacturer’s instructions, and 1 µg of RNA was added per reaction. After 1-h incubation at 30 °C, 
IVRA reactions were terminated by the addition of LiDS/LET containing 80 µg/mL proteinase K and 
incubating for 15 min at 37 °C. Unicorporated label was removed using RNase-free Micro Bio-Spin™ 
P-30 Gel Columns (Bio-rad, Berkeley, CA, USA), and RNA was isolated using the acid phenol 
method. 
The acid phenol method was used to isolate total RNA from IVRA samples as well as cell 
lysates, PNS, P15, and S15 prepared from SFV-infected BHK-21 cells. RNA was extracted with acid 
phenol:chloroform, premixed with isoamyl alcohol (125:24:1 phenol:chloroform:isoamyl alcohol; pH 
4.5; Ambion), precipitated with isopropyl alcohol, and washed with 70% ethanol. TRIzol® Reagent 
(Invitrogen) was used to isolate total RNA from PNS, P15, and S15 fractions prepared from 
transfected BSR cells according to the manufacturer’s instructions. In both methods, GlycoBlue 
(Ambion) was used as a coprecipitant and isolated RNA was dissolved in 1 mM sodium citrate (pH 
6.4; Ambion). Isolated RNA was analysed by denaturing formaldehyde agarose gel electrophoresis 
as described previously [37], except that 1.0% (w/v) agarose gels were used. 
PNS, P15, and S15 fractions prepared from BSR cells co-transfected with P1^2^3HA4 and Tmed 
were treated with RNase Cocktail™ Enzyme Mix (Ambion) containing RNase A and T1 (final 
concentrations of 5 and 205 units/mL, respectively). Incubation was in DB (low salt conditions) for 
15 min at 37 °C, and RNA was isolated using TRIzol® Reagent and analysed as above. 
In-gel hybridization to detect RNA molecules from dried gels with 32P-labeled oligonucleotides 
was performed as described in [37]. All hybridizations were done at 55 °C. Negative-stranded 
SFV4-HA RNA was detected with the probe HybSFV4neg_4 (5′-GTATCATGTGAAGGGT 
ACGTAGTTAAGA-3′) that corresponds to nucleotides 926–953 of genomic RNA and thus 
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recognizes the minus-strand RNA. Genomic and subgenomic RNA of SFV4-HA were detected with 
the probe HybSFV4pos_5 (5′-GCTTTGTTACAAGTTATACAGTTATGGTTATATG-3′) that is 
complementary to nucleotides 11,292–11,325 and thus detects the plus-strand RNA. 
Negative-stranded Tmed RNA was visualized using the probe HybSFV4neg 
(5′-CAAAAGATTTTGTTCCAGCTCCTG-3′) corresponding to nucleotides 28–51 of the Tmed 
transcript. Positive-stranded genomic and subgenomic RNA of Tmed were detected with the probe 
HybTmedpos_2 (5′-TTAAGCTCTAATTAATTAGTCGACCTACTTGTAC-3′) that is complementary 
to nucleotides 2807–2840. All 18S ribosomal RNA (rRNA) was detected with the oligonucleotide 
probe 5′-ATGCCCCCGGCCGTCCCTCT-3′. If the same gel was hybridized with different probes, 
the gel was stripped between hybridizations by incubating in 1% SDS at 80 °C and confirming that 
no signal remained by phosphorimaging as described below. 
All 32P-labeled RNA was detected by exposing Phosphor Imager screens to dried gels and 
scanning the screens with a Typhoon 9410 imager (GE Healthcare, Chicago, IL, USA). Incorporated 
label was quantified by Quantity One software (Bio-rad). 
2.6. Hybridization of 32P-labeled RNA Products with Capture Probes 
In vitro transcripts containing nucleotides 8390–11,468 of SFV4-HA genomic RNA (capture 
probe for minus strands) and its complementary sequence (capture probe for plus strands), 
nucleotides 1–2963 of Tmed RNA (capture probe for minus strands), nucleotides 1–2878 of Tmed 
negative-sense RNA (capture probe for plus strands), and nucleotides 1–2042 of equine arteritis 
virus (EAV) genome were prepared using mMESSAGE mMACHINE® T7 or SP6 Transcription Kit 
(Ambion) according to the manufacturer’s instructions. SacI-linearized Tmed or XhoI-linearized 
pEAV221Δ plasmids were used as templates for Tmed and EAV in vitro plus transcripts, 
respectively. pEAV221Δ was obtained by cleaving pEAV221 [39] with HindIII and ligating the 
4729-bp fragment. For Tmed minus transcript, a PCR product made using oligos 
5′-ATGTGGCAACATTTAGGTGACACTATAGAAGAATTGCAAAATAAAATAAAAATC-3′ and 
5′-ATGACGGATGTGTGACATAC-3′ was used as a template. For SFV4-HA, a PCR product made 
using oligos 5′-ACGTGGCAACTAATACGACTCACTATAGGGTGGATAGGCCAGGGTACTAC-3′ 
and 5′-ATGTGGCATCATTTAGGTGACACTATAGAAGACCAATTGCAAAATAAAATAAAAAT 
CC-3′ was used as a template. One microgram (1 µg) of each transcript was immobilized to 
Hybond-N+ membrane (GE Healthcare). The membranes were prehybridized in a hybridization mix 
[37] for 24 h at 55 °C. Then, the membranes were hybridized with IVRA products for 16 h at 55 °C, 
washed with 5× SSPE (0.9 M NaCl, 50 mM NaH2PO4, 5 mM EDTA, pH 7.4) and 0.05% SDS, and 
exposed to Phosphor Imager screens. To test the specificity of the capture probes, the membranes 
were also hybridized with 32P-labeled minus and plus transcripts of the SFV4-HA and Tmed 
described above. The labeled transcripts were prepared using a T7 or SP6 Transcription Kit 
according to the manufacturer’s instructions, except for that a nucleotide mix containing 20 µM ATP, 
UTP, CTP, and GTP and 0.12 µM (10 µCi) of α-32P-CTP (Perkin Elmer) were used. 
2.7. 35S-Labeling and Protein Analyses 
Protein concentrations were measured by the Coomassie blue method [40] using BSA as a 
standard. The 35S-L-methionine and 35S-L-cysteine labeling was performed using PNS prepared from 
mock BSR cells or cells co-transfected with P123HA4 and Tmed. The 35S-labeling was performed in the 
same buffer conditions as IVRA by incubating the samples with 22 µCi of EasyTag™ EXPRESS35S 
Protein Labeling Mix (Perkin Elmer) for 1 h at 30 °C. Unicorporated label was removed using 
RNase-free Micro Bio-Spin™ P-30 Gel Columns (Bio-rad), and proteins were separated by 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with 4% and 12% (w/v) acrylamide 
concentrations in the stacking and separation gels, respectively. SDS-polyacrylamide gels were 
stained with Coomassie blue to show total protein composition. All 35S-labeled proteins were 
detected by drying the gels and exposing them to Phosphor Imager screens. If samples were heat 
inactivated, they were incubated for 5 min at 96 °C before the labeling. If translation inhibitors were 
used, samples were incubated with puromycin (100 µg/mL; GE Healthcare) or cycloheximide (100 
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µg/mL; Sigma-Aldrich) for 60 min at 4 °C before the labeling. The same pre-incubation was also used 
when translation inhibitors were tested in IVRA. 
For Western blotting, proteins were separated by SDS-PAGE with 4% and 10% (w/v) acrylamide 
concentrations in the stacking and separation gels, respectively, and transferred to AmershamTM 
ProtanTM Nitrocellulose Blotting Membrane (GE Healthcare). After blocking with 5% (w/v) non-fat 
dry milk powder in Tris-buffered saline (TBS), membranes were incubated with rabbit polyclonal 
antibodies against SFV nsP1, nsP2, nsP3, or nsP4 [41] or mouse monoclonal anti-HA antibody 
(Sigma-Aldrich) in TBS with 5% milk and 0.1% (v/v) Tween-20. Mouse monoclonal antibody against 
β-actin (Sigma-Aldrich) was used as a cytosolic marker. Secondary antibodies IRDye® 800CW 
donkey anti-rabbit IgG (LI-COR Biosciences, Lincoln, NE, USA) and Alexa Fluor 680 donkey 
anti-mouse IgG (Invitrogen) were used for fluorescent detection of the primary antibodies with an 
Odyssey system (LI-COR). Quantification was performed using Image Studio Software (LI-COR). 
3. Results 
3.1. Isolation of Active Replication Complexes from SFV-Infected Cells 
Metabolic labeling of SFV RNA synthesis with 3H-uridine was used to determine the optimal 
time point for the isolation of active SFV RCs. BHK cells were infected with an MOI of 50, and the 
incorporation of label into viral genomic (42S) and subgenomic (26S) RNA species became detectable 
after 1.5 h.p.i. (Figure 1A,B). The rate of 3H-uridine incorporation into viral RNA reached a 
maximum level at 4–5 h.p.i. Thus, SFV-infected cells were harvested at 4 h.p.i. and homogenized in 
isotonic buffer to prepare PNS. Typically, the PNS samples had a total protein concentration of ~3 
mg/mL. To further isolate the RCs, PNS was separated into a P15 pellet and S15 supernatant by 
differential centrifugation at 15,000× g, and the distribution of viral nsPs as well as RNA was studied. 
The cytosolic marker β-actin and 18S rRNA were predominantly found in the S15 fractions (Figure 
1C,D). Western blotting showed that all four nsPs were present in PNS, as well as in the P15 and S15 
fractions (Figure 1C). The P15 fraction contained the majority of nsP1 (~90%) and about half of nsP4. 
Approximately 30% and 40% of nsP2 and nsP3 were found in P15, respectively. In-gel 
hybridizations showed that the P15 fraction contained the majority (~80%) of the minus-strand RNA 
present in the PNS, while a minor fraction of the genomic plus-strand RNA (~20%) was found in P15 
(Figure 1D). 
The RNA-synthesizing activity present in the PNS, P15, and S15 fractions was analysed by 
measuring the incorporation of 32P-CTP into viral RNA in an IVRA (Figure 1E). No labeled RNA was 
detected in the mock PNS, while the PNS prepared from SFV-infected cells synthesized three RNA 
species corresponding to SFV genomic and subgenomic RNA, as well as an RNA species designated 
as RNA II, in line with other alphaviruses [25,33]. The genomic RNA was the major product 
synthesized in vitro, and RNA II was only detected in the 32P-labeled reaction products of the in vitro 
assay, not in the 3H-uridine-labeled viral RNA synthesized in cells (Figure 1A,E). This might be due 
to the short half-life of RNA II in the infected cells or due to the lack of sensitivity in detecting 
3H-labeled RNA compared to 32P-labeled molecules. Approximately 9% and 49% of the in vitro 
replication activity present in the PNS was recovered in the S15 and P15 fractions, respectively 
(Figure 1E). The membrane fraction prepared from severe acute respiratory syndrome 
(SARS)-coronavirus-infected cells is inactive in replication in vitro unless a cytosolic fraction is 
added in the reaction mixture [42]. However, mixing of the S15 and P15 did not restore the full 
replication activity of SFV (69% of that in the PNS), indicating that the factors in the S15 fraction are 
dispensable for replication and that the differential centrifugation likely caused damage to RCs, 
leading to a partial loss of activity. The slight boost after mixing P15 and S15 was most likely due to 
the cellular NTP pool present in S15. 
3.2. Application of the in Vitro Replication Assay to the Trans-Replication System 
BSR cells were co-transfected with the SFV replicase and template plasmids to determine if the 
RCs isolated from the trans-replication system are active in RNA synthesis in vitro. PNS was 
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prepared from the transfected cells at 16 h post transfection using the same method as optimized for 
SFV-infected cells. The wild-type replicase polyprotein, P1234, as well as the polymerase inactive 
mutant, P1234GAA, were included in this study. In addition, two partially uncleaved polyproteins 
were used. In P1^2^34, cleavage sites between nsP1 and nsP2 as well as nsP2 and nsP3 have been 
mutated, resulting in the polyprotein P123 and nsP4. In P12CA3, the active site of the nsP2 protease 
has been mutated, and nsP4 is expressed from a separate plasmid as an ubiquitin–nsP4 fusion. The 
Tmed plasmid that expresses a 2963-nt RNA containing the 5′ and 3′ untranslated regions (UTRs) 
and the subgenomic promoter was provided as a template plasmid [26]. 
 
Figure 1. Kinetics of Semliki Forest virus (SFV) RNA synthesis and isolation of active replication 
complexes for in vitro analysis. (A) SFV-infected baby hamster kidney (BHK) cells were 
pulse-labeled with 3H-uridine for 1 h during the time periods indicated. After labeling, RNA was 
isolated, analysed by denaturing agarose gel electrophoresis, and visualized by fluorography. The 
positions of genomic and subgenomic RNA are indicated; (B) Liquid scintillation counts of the same 
RNA as in A; (C) Expression of the replicase proteins and their distribution between the P15 and S15 
fractions as studied by Western blotting with specific antibodies. Distribution of the cytosolic marker 
β-actin is also shown. Post-nuclear supernatant (PNS) was prepared at 4 h post infection (p.i.), and 
equivalent amounts of PNS, P15, and S15 were analysed from mock- and SFV-infected cells. Data are 
a representative example of two independent experiments; (D) Distribution of SFV minus- and 
plus-strand RNA determined by in-gel hybridization with a probe specific to minus- or plus-strand 
RNA. The probe against plus-strand RNA detects both genomic and subgenomic RNA. As a control, 
a probe against ribosomal 18S RNA was used; (E) RNA synthesizing activity of various subcellular 
fractions analysed in vitro by determining incorporation of 32P-CTP into RNA. After an in vitro 
replication assay (IVRA), RNA was analysed in a denaturing agarose gel. P+S indicates a mixture of 
equal volumes of P15 and S15 from SFV-infected cells. 18S rRNA was detected by in-gel 
hybridization of the same gel. Representative experiments are shown in (D) and (E). 
Similar to the PNS from SFV-infected cells, PNS samples prepared from transfected cells gave a 
total protein concentration of approximately 3 mg/mL and all four nsPs were detected (Figure 2). 
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The results of the fractionation of transfected-cell PNS into S15 and P15 were also comparable to 
those obtained with virus-infected cells, as β-actin and 18S rRNA were mostly found in the S15 
fractions (Figures 2 and 3). nsP4 was enriched in P15 (~50–70%), except in P1234GAA, where the 
majority of nsP4 was found in S15 (~80%). The P15 fraction of the cleavable constructs, P1234 and 
P1234GAA, contained the majority of nsP1 (~90 and 80%, respectively). Approximately 30% and 20% 
of nsP2 and ~50 and 40% of nsP3 were found in P15 of P1234 and P1234GAA, respectively. The 
polyprotein P123 was detected when cells were transfected with the uncleavable constructs, P1^2^34 
or P12CA3, and the majority was distributed in P15 (~80 and 90%, respectively). Besides the 
polyprotein P123, bands recognized by anti-nsP1 and anti-nsP2 antibodies were detected in these 
samples. Their size was slightly smaller compared to nsP1 and nsP2 in the cleavable constructs, and 
thus they most likely represent unspecific cleavage products. Approximately 90% of the band 
detected by the anti-nsP1 antibody was found in P15. However, the unspecific cleavage product of 
nsP2 was also mainly found in the membrane fraction (~80%) in contrast to nsP2 in cells infected 
with SFV or transfected with the wild-type replicase, in which the majority of nsP2 was recovered in 
the cytosolic fraction (Figures 1 and 2). No processed nsP3 was observed in cells transfected with the 
uncleavable constructs, which may be due to its instability and rapid turn-over. The only major 
difference observed between cells transfected with the two uncleavable constructs was that the 
P12CA3 + nsP4-transfected cells contained more nsP4, most likely due to its expression from a 
separate plasmid. 
 
Figure 2. Distribution of nsPs expressed in transfected cells. BSR cells were transfected with the 
replicase plasmid(s) indicated at the top and Tmed template plasmid. At 16 h post transfection, PNS 
was prepared and fractionated into P15 and S15, and nsPs were detected by Western blotting with 
specific antibodies. The polyprotein P123 was recognized using anti-nsP3 antibody. β-actin was used 
as a cytosolic marker. Equivalent amounts of PNS, P15, and S15 were loaded. Two independent 
experiments were performed and one representative result is shown here. 
We next assessed the presence and distribution of endogenous RNA in the transfected samples. 
No signal was detected when RNA from mock-transfected or P1234GAA + Tmed-transfected cells was 
analysed by in-gel hybridizations with probes specific for the template RNA (Figure 3A). Both 
minus- and plus-strand RNA were detected in PNS when the wild-type replicase and uncleavable 
constructs together with the template were expressed (Figure 3A). Cells expressing the uncleavable 
construct P1^2^34 + Tmed contained a considerably higher amount of the minus-strand RNA 
compared to those expressing the wild-type construct P1234 + Tmed. Cells transfected with the 
wild-type replicase and Tmed contained significantly higher amounts of the genomic and 
subgenomic plus strands when compared to the uncleavable replicase (Figure 3A). In both cases, the 
S15 fraction contained more plus-strand RNA, while the minus-strand RNA was distributed more 
evenly. Thus, it was studied if the minus-strand RNA is in a nuclease-protected form in both the 
membrane and cytosolic fractions. PNS, P15, and S15 fractions from P1^2^34 + Tmed were treated 
with RNase A/T1 under low salt conditions to digest both single- and double-stranded RNA. The 
digestion of 18S rRNA was observed in all treated samples, confirming that the RNase treatment 
was effective (Figure 3B). More minus-strand RNA was digested in PNS and S15 than in P15, but all 
fractions contained at least 80% of the minus-strand RNA present in their corresponding untreated 
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sample (Figure 3B). This indicates that the minus-strand RNA was mostly protected from the 
nucleases and not in a freely accessible form. Furthermore, most of the plus-strand RNA present in 
the PNS and S15 was digested, while in P15 the plus-strand RNA was protected. This confirms the 
idea that the plus-strands in replicative intermediates within the RC are membrane-protected, while 
they are released from the RCs into the cytosol in a more nuclease-sensitive form (Figure 3B). 
To study replication activity, IVRAs were performed with the samples prepared from the 
transfected cells. PNS from both mock-transfected cells and those transfected with the inactive 
polymerase mutant (P1234GAA + Tmed) gave some background, most likely from the T7 polymerase 
that is expressed in BSR cells (Figure 4). However, the wild-type replicase with the template was 
highly active in synthesizing both genomic and subgenomic RNA. RNA II was not observed, which 
may be due to its short half-life in combination with a lower activity of the RCs from transfected cells 
compared to those from infected cells. The P15 and S15 fractions prepared from cells transfected 
with P1234 + Tmed contained 38% and 15% of the replication activity present in the PNS, 
respectively (Figure 4). A combination of P15 and S15 gave a yield of 53%. In contrast to the 
wild-type replicase, the uncleavable constructs P1^2^34 and P12CA3 + nsP4 replicated the 
endogenous template poorly, although they produced RNA species with sizes corresponding to 
both genomic and subgenomic Tmed. However, the smaller RNA species was detected in the 
polymerase mutant as well and thus might be the result of another (background) activity. In 
addition, an unspecific product was observed in all constructs with a size below that of the 
subgenomic RNA. The higher expression levels of nsP4 most likely explain why P12CA3 + nsP4 
produced more labeled RNA than P1^2^34 (Figures 2 and 4). 
 
Figure 3. Distribution and stability of endogenous minus- and plus-strand RNA in P15 and S15 
fractions prepared from transfected BSR cells. (A) PNS was prepared at 16 h post transfection, and 
total RNA was isolated from equivalent amounts of PNS, P15, and S15 followed by in-gel 
hybridization with probes that detect either minus- or plus-strand RNA. Subgenomic (SG) RNA is 
indicated by Tmed SG. Numbers below the lanes indicate the percentage of 32P-label detected in the 
genomic RNA compared to PNS. For the plus-strand RNA, the genomic Tmed was quantified. As a 
control, a probe against ribosomal 18S RNA was used; (B) PNS, P15, and S15 from cells 
co-transfected with the P1^2^34 and Tmed constructs were treated with RNase A/T1 under low salt 
conditions, and RNA was detected as in A. Numbers below the lanes indicate the percentage of 
32P-signal in genomic RNA compared to the untreated sample. Representative experiments are 
shown. 
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Figure 4. In vitro activity of replication complexes formed by expressing different SFV replicase 
constructs and a template in the trans-replication system. BSR cells were transfected and PNS, P15, 
and S15 were prepared as in Figure 3. Replication activity was determined by measuring the 
incorporation of 32P-CTP into viral RNA after separation in denaturing agarose gels. The genomic 
and subgenomic RNA are indicated by Tmed and Tmed SG, respectively. P+S indicates a reaction 
containing equal volumes of P15 and S15 fractions, and each reaction contained an equivalent 
amount of PNS, P15, or S15. The arrow indicates an unspecific band. Ribosomal 18S RNA was 
detected by in-gel hybridization of the same gel. Data are representative of at least two independent 
experiments. 
3.3. Polarity of SFV RNA Synthesized in Vitro 
We next examined the polarity of the RNA synthesized in vitro by the RCs isolated from 
SFV-infected BHK and transfected BSR cells. These RNA species were compared to in vitro 
transcripts of SFV or Tmed of positive or negative polarity. Some 32P-labeled IVRA products were 
denatured and hybridized with membrane-immobilized capture probes specific to positive or 
negative polarity SFV RNA. A capture probe corresponding to 1–2042 nt of EAV genome was used 
as a (negative) control for binding specificity. The IVRA products synthesized by SFV RCs strongly 
hybridized with the capture probe for the plus-strand RNA, indicating that SFV RCs mainly 
produced RNA of positive polarity in vitro (Figure 5A). Capture probes specific to the Tmed 
template of the trans-replication system gave more background, and thus the signal was quantified 
(Figure 5B,C). The IVRA products made by RCs from P1234 + Tmed-transfected cells showed similar 
binding to the capture probes as the plus-strand RNA transcript of Tmed. The RNA products 
synthesized by RCs formed upon expression of P1^2^34 + Tmed also produced a similar binding 
pattern as the plus-strand RNA transcript. The IVRA products made by P1234GAA + Tmed showed 
significant binding only to the plus-RNA capture probe and the binding was approximately 67% of 
the binding to the plus-RNA capture probe detected with P1^2^34 + Tmed, suggesting that the signal 
generated by this uncleavable replicase was mostly or in part due to some background activity. 
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Figure 5. Determination of the polarity of in vitro synthesized RNA. (A) RNA probes with the 
sequence of the 3′ end of the SFV genome, recognizing minus-strand RNA (RNA−), or its 
complementary sequence, recognizing plus-strand RNA (RNA+), were immobilized on membranes. 
As a negative control, an unrelated transcript (equine arteritis virus (EAV)) was also immobilized. 
The membranes were then hybridized with 32P-labeled SFV transcripts of positive or negative 
polarity as well as 32P-labeled IVRA products. IVRA reactions with PNS samples from mock and 
SFV-infected cells were included; (B) RNA probes with the plus sequence of Tmed, recognizing 
minus-strand RNA (RNA−), or its complementary sequence, recognizing plus-strand RNA (RNA+), 
were immobilized on membranes as well as EAV transcript followed by hybridization with 
32P-labeled Tmed plus and minus transcripts as well as 32P-labeled IVRA products. PNS samples 
from both mock and transfected cells were included; (C) binding of Tmed plus and minus transcripts 
as well as IVRA products to the capture probes was quantified from two independent experiments. 
The binding of the IVRA products made by replication complexes (RCs) from P1^2^34 or P1234GAA + 
Tmed-transfected cells were normalized to the binding of the IVRA products made by RCs from 
P1234 + Tmed-transfected cells. Magenta indicates binding to the capture probe for the plus-strand 
RNA and orange to the capture probe for the minus-strand RNA. 
3.4. Effect of Ongoing Translation on in Vitro RNA Synthesizing Activity 
To determine if in vitro RNA synthesizing activity requires ongoing protein synthesis (which 
might result in the de novo formation of complexes) we studied the effect of translation inhibitors. 
We first established whether translation occurred when PNS samples were incubated under IVRA 
conditions by metabolic labeling of protein synthesis with 35S-Met and 35S-Cys. Metabolic labeling 
was performed on mock PNS, heat-inactivated mock PNS, and PNS prepared from BSR cells 
co-transfected with the wild-type replicase and Tmed template. Coomassie staining demonstrated 
that these samples contained similar amounts of total protein (Figure 6A). A synthesis of 35S-labeled 
proteins was readily detected in mock PNS and replicase-expressing PNS (Figure 6B), despite the 
fact that the IVRA reaction conditions might not be optimal for protein synthesis. Heat inactivation 
of PNS prior to metabolic labeling abolished the incorporation of 35S (Figure 6B), confirming that the 
radioactive signal in lanes 2 and 3 of Figure 6B is the result of translation. The translation inhibitors 
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puromycin and cycloheximide were added to PNS prior to metabolic labeling, and this inhibited the 
de novo production of proteins in vitro as the incorporation of 35S into proteins was no longer 
observed, while the total protein content of the samples was practically unaffected (Figure 6C,D). 
When these translation inhibitors were added during IVRA, the RNA synthesizing activity remained 
unchanged (Figure 6E), demonstrating that ongoing protein synthesis is not required for RNA 
synthesis in vitro. 
 
Figure 6. In vitro RNA-synthesizing activity is not dependent on translation. BSR cells were either 
mock-transfected or co-transfected with the P1234 and Tmed constructs, and PNS was prepared at 16 
h post transfection. (A) Protein profiles of PNS samples in an SDS-polyacrylamide gel stained with 
Coomassie blue. One of the mock PNS samples was heat inactivated, and then all samples were 
incubated with 35S-L-methionine and 35S-L-cysteine. Numbers on the left indicate the molecular 
masses (kDa) of marker proteins; (B) a Phosphor Imager screen was exposed to the same gel as in A 
to detect 35S-labeled proteins; (C) PNS samples from the cells transfected with P1234 + Tmed were 
treated with translation inhibitors, puromycin or cycloheximide, and then incubated with 
35S-methionine and 35S-L-cysteine. Protein profiles in an SDS-polyacrylamide gel stained with 
Coomassie blue are shown; (D) A Phosphor Imager screen was exposed to the same gel as in C to 
detect 35S-labeled proteins; (E) P1234 + Tmed PNS was treated with translation inhibitors as in C 
followed by an IVRA. 18S rRNA was detected by in-gel hybridization of the same gel. The results of 
one of two independent experiments is shown. 
3.5. Purification of Replicase Protein-Containing Membranes and Addition of Exogenous Template RNA 
To gain more insight into the function of the early RC formed by the polyprotein P123 and 
polymerase nsP4, we expressed the uncleavable construct P1^2^34 without the template RNA in 
BSR cells. Cells were harvested at 6 and 16 h post transfection, and membranes containing the 
polyprotein and polymerase were mixed with an in vitro transcribed RNA to study if they were able 
to replicate an exogenous template. However, the added RNA was rapidly degraded in the P15 
fraction, and thus RC-containing membranes were further purified from PNS. First, we tested 
HA-specific affinity capture using HA-tagged nsP3. Western blotting showed that the polyprotein 
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P123 or nsP4 did not bind to the HA-specific agarose beads (Figure 7A). When the cleavable 
polyprotein P1234 was expressed in cells, we observed binding of nsP3 (Figure 7A). However, nsP4 
did not bind in this case either, indicating that bound nsP3 was not in a complex with the other nsPs. 
Thus, we next tested the purification of membranes using flotation centrifugation in an iodixanol 
step-gradient. The light-scattering band was collected and Western blotting confirmed the presence 
of the polyprotein P123 and nsP4 in the membrane fractions (Figure 7B). Next, the membrane 
fractions were provided with an exogenous template, the positive polarity in vitro transcript of 
Tmed, and IVRAs were performed. In-gel hybridization confirmed the presence of significant 
amounts of exogenous Tmed RNA transcript in both membrane fractions after the IVRA had been 
performed (Figure 7C, lower panel). The membrane fraction prepared from the cells harvested at 6 h 
post transfection contained more in vitro transcript than the sample prepared 16 h post transfection, 
suggesting that RNase activity was somewhat higher in the flotation samples prepared from cells at 
the later time point post transfection. Although exogenous Tmed transcript was present throughout 
the incubation with the membrane fractions, no incorporation of 32P-CTP into viral RNA was 
detected (Figure 7C, upper panel), despite the fact that template RNA was still present at the end of 
the reaction (Figure 7C, lower panel). 
Besides the T7 promoter-driven replicase constructs that were expressed in BSR T7/5 cells, we 
also used BHK-21 cells that were transfected with plasmids that express replicase proteins under 
control of the cytomegalovirus promoter. P1^2^34 replicase-containing membrane fractions from 
these cells were also unable to replicate the exogenous template. To exclude that the lack of activity 
was due to the template itself, we also tested a smaller RNA template, Tshort (1529 nt), without 
success. To give the complex more time to form, we also pre-incubated P1^2^34 replicase-containing 
membrane preparations with an exogenous template for 1 h at 4 °C before the reaction was 
performed, and we tested different reaction times from 30 min to 2 h. None of these experimental 
variations resulted in the replication of the exogenous template. 
 
Figure 7. Exogenous template RNA is not replicated in vitro. (A) BSR cells were transfected with the 
polyprotein construct P1^2^34 or P1234 and cells were collected at 16 h post transfection followed by 
homogenization and HA-affinity capture. The HA tag was in nsP3. After PNS was incubated with 
HA-specific agarose beads, they were washed and boiled with Laemmli sample buffer. The presence 
of polyprotein P123, nsP3, nsP4, and β-actin in PNS as well as in unbound and bound fractions was 
studied by Western blotting. P123 and nsP3 were detected using an antibody against the HA tag; (B) 
BSR cells were transfected with the polyprotein construct P1^2^34, cells were collected at 6 or 16 h 
post transfection, and membranes were purified from PNS using flotation centrifugation. A Western 
blot analysis shows the presence of P123, nsP4, and β-actin in the PNS and membrane fractions (fr.); 
(C) IVRA was performed with the flotation fractions by adding 1 µg of Tmed in vitro transcript. As a 
control, replication activity from the endogenous template is shown for PNS prepared from BSR cells 
co-transfected with the P1234 and Tmed constructs. The lower panel shows the presence of 
exogenous Tmed transcript in the membrane fractions after the IVRA, detected by in-gel 
hybridization from the same gel using a probe specific to the plus-stranded Tmed. 
4. Discussion 
Herein, we analysed SFV replication using a combination of in vitro activity and 
trans-replication systems. The results described in this study revealed the main requirements for 
RNA synthesis in vitro and are summarized in Figure 8. At least three independently prepared 
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batches of PNS, P15, and S15 from infected and transfected cells produced very similar results 
(activities), showing the robustness of the system. 
Highly active RNA synthesis was observed in vitro only when RCs were isolated from cells 
containing the fully processed SFV replicase, either resulting from virus infection or transfection 
with the wild-type replicase and template plasmids (Figures 1 and 4). Highly diluted PNS from 
infected cells was routinely used in the IVRA, demonstrating the robustness of the in vitro 
RNA-synthesizing activity of SFV. Albeit less active, the RCs isolated from transfected cells were 
also functional in making both genomic and subgenomic RNA (Figure 4). A combination of the in 
vitro RNA synthesis assay and trans-replication system can also be applied to study the replication 
of CHIKV, as a trans-replication system is available for this highly pathogenic alphavirus as well 
[28]. 
 
Figure 8. Schematic representation of the possible activities of various RCs that can be produced with 
the trans-replication system. (A,B) When cells are transfected with the partially uncleavable replicase 
and template constructs, PNS shows very little activity in vitro indicated by the white arrows. A 
minor amount of plus-strand RNA is made, and it is also possible that RCs finish initiated minus 
strands. These complexes represent early RCs; (C) when cells are infected or transfected with the 
wild-type replicase and template constructs, the prepared PNS is highly active in vitro and 
synthesizes RNA of positive polarity, both genomic and subgenomic, indicated by the orange 
arrows. These complexes are late RCs. 
Infection and the trans-replication system only yielded isolated RCs that synthesized 
exclusively plus-strand RNA (Figure 5). These complexes thus represent late-stage RCs formed by 
nsP1 to nsP4 and are dedicated to the synthesis of plus strands [8,21]. Here, the optimal time point to 
isolate active RCs from SFV-infected cells was around 4 h.p.i. (Figure 1), and thus the observed 
plus-strand synthesis is consistent with SFV minus-strand synthesis ceasing between 3 and 4 h.p.i. in 
mammalian cells [43]. Furthermore, our and previous metabolic labeling studies of SFV-infected 
cells also indicate that viral replication is maximal at this time [32]. Endogenous minus strands and 
replication activity were mainly found in the membrane fraction prepared from SFV-infected cells, 
while endogenous plus strands were more abundant in the cytosolic fraction (Figure 1). The same 
has been observed with CHIKV-infected cells [25], and confirms the idea that the membranous 
spherules accommodate the minus-strand RNA as well as the active replication complex [23–25]. 
Interestingly, the cytosolic fractions from the trans-replication system contained more minus-strand 
RNA than those from infected cells. However, the minus-strand RNA in the cytosolic fraction from 
transfected cells was insensitive to RNases (Figure 3), suggesting it is in spherules or other protective 
structures. This is also supported by the observation that the ratio of the activity between the S15 and 
P15 fractions was higher in the samples prepared from the transfected cells than in those obtained 
from infected cells (Figures 1 and 4). These differences in spherule distribution might be explained 
by their subcellular location. With the infection conditions described here, SFV spherules are mainly 
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located in small endocytic vesicles and perinuclear cytopathic vacuoles [18]. In the trans-replication 
system, spherules mainly stay at the plasma membrane [29]. 
The partially uncleaved replicase protein produced considerably higher amounts of the 
minus-strand RNA and considerably smaller amounts of the plus-strand RNA in cells, compared to 
the wild-type replicase (Figure 4). It has been observed that the early RCs consisting of P123 and 
nsP4, although primarily synthesizing minus strands, are also able to make plus strands [6,8,21,24], 
albeit inefficiently compared to late-stage RCs. However, it is intriguing how dramatic the difference 
in the minus-strand RNA synthesis was. If we assume that minus strands represent RCs, our results 
imply that the partially uncleaved replicase is able to make significantly higher numbers of RCs 
compared to the wild-type replicase. This suggestion is in line with the requirement of partially 
uncleaved replicase to form spherules without the template [29]. Furthermore, Western blotting 
showed that in all replicase constructs the polymerase nsP4 was enriched in the membrane fraction, 
with the exception that in P1234GAA it did not become membrane-associated but mainly remained 
free in the cytosol (Figure 2). Because the spherule assembly without active viral replication is 
achieved only if P23 remains uncleaved [29], RCs are not formed using a fully cleaved construct 
P1234GAA, and consequently nsP4 stays cytosolic, explaining our results. Thus, the recruitment of 
nsP4 to the RC requires its catalytic activity and the presence of a template RNA. 
Besides replication, active translation was observed in the SFV in vitro system (Figure 6), 
similar to PNS prepared from SARS-coronavirus-infected cells, for which ongoing protein synthesis 
was not required for in vitro replication activity [42]. Likewise, the activity of isolated SFV RCs did 
not require ongoing translation in the in vitro assay (Figure 6), suggesting that (the bulk of) the 
activity that is measured in our assay can be attributed to the existing isolated RCs and that new RCs 
that might be formed (if at all) de novo during the reaction do not contribute significantly. 
Translation inhibitors did not boost replication either, indicating that ribosomes caused no 
significant stall of the polymerase complex. In SFV-infected cells, which synthesize both minus and 
plus strands, translation inhibitors cause selective shut off of the minus-strand RNA synthesis [43]. 
However, overproduction of the nonstructural proteins does not lead to increased RNA synthesis in 
SFV-infected cells [44]. 
The in vitro replication and capture probe experiments showed that the partially uncleaved 
replicases had a very poor in vitro replication activity on an endogenous template (Figures 4 and 5). 
The amount of radiolabeled RNA that was produced in vitro by P1^2^34 was only slightly above the 
background levels that were observed when the inactive polymerase mutant was used, although 
P1^2^34 produced high levels of the minus-strand RNA in cells (Figures 3–5). This indicates that 
after P123 and nsP4 have formed early RCs and synthesized the minus-strand in cells, they do not 
continue to make additional minus strands (in vitro). This is supported by the observation that a 
translation inhibitor blocks continuous minus-strand synthesis in SFV- and SINV-infected cells 
[43,45]. Furthermore, membranes containing the polyprotein P123 and polymerase nsP4 were 
unable to initiate RNA synthesis in vitro using an exogenous template (Figure 7). As it has been 
shown that the partially uncleaved replicase forms spherules without the template [29], we speculate 
that the proteins were sequestered in spherules and did not have access to and so could not recruit 
the cytosolic template. 
Introduction of the HA-affinity tag in the nonstructural protein 4B (NS4B) has been used to 
purify hepatitis C virus (HCV) RCs [38]. NS4B is a membrane protein, and the scaffolding protein 
HCV RCs and affinity capture resulted in an enrichment of DMVs capable of the de novo synthesis 
of HCV RNA. Thus, we also probed a similar approach to isolate SFV replicase proteins by tagging 
nsP3, which is known to tolerate insertions [18]. However, HA-affinity capture could not be used to 
purify complexes of P123 and nsP4 or complexes of nsP3 and nsP4; only nsP3 bound to the capture 
beads (Figure 7) and most likely represented cytoplasmic aggregates of nsP3 [46,47], supporting our 
hypothesis that nsPs engaged in replication are sequestered in spherules. Consequently, the results 
indicate that the minus-strand synthesis requires that RCs or spherules are assembled at the same 
time as the minus-strand synthesis is initiated, and this was not achieved in vitro because the 
replicase proteins had already formed spherules. The recent cryo-electron tomographic 
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reconstruction of Flock House virus (FHV) spherules also suggests that the minus-strand is 
synthesized simultaneously with spherule formation [23]. However, although the minus-strand 
synthesis seems to depend on the RC assembly, SFV spherule formation does not depend on viral 
RNA replication [29]. 
It is intriguing that the uncleavable polyprotein P123 and polymerase nsP4 of SINV are able to 
start the minus-strand synthesis from an exogenous template in a recombinant vaccinia virus 
expression system [30] in contrast to the results obtained with our SFV expression system. However, 
SINV P123 and nsP4 are also able to form spherules without the template [29], and it will be 
interesting to test if these replicase proteins are able to replicate an exogenous RNA template, when 
expressed analogously to the SFV system we have used in this study. Furthermore, it will be 
important to compare this system to the vaccinia virus-based expression system used in the previous 
SINV studies. Interestingly, SINV nsP4 purified from Escherichia coli synthesizes RNA in vitro if 
combined with a P123-membrane fraction and template RNA [16], and thus it might be that in the 
vaccinia virus-based expression system there are P123 and nsP4 proteins which have not yet formed 
spherules and are thus able to recruit and replicate an exogenous template. 
In this study, we showed that SFV polyprotein P123 and polymerase nsP4 were active in RNA 
replication only in cells, and after isolation these early RCs were unable to effectively synthesize 
RNA in vitro. In contrast, the polymerase nsP4 together with nsP1, nsP2, and nsP3 was highly active 
in vitro and these late RCs could be isolated for in vitro analyses. The next step to shed light on the 
mechanisms and molecular details that underlie the differences between the early and late RCs 
would be to analyse their formation from template recruitment to RNA synthesis and membrane 
deformation. This will, however, require that we freeze RC assembly at different stages. It has been 
shown that P123 alone does not form spherule structures [29]. Thus, an interesting model system 
could be provided by the purified nsP4 combined with a P123-membrane fraction and template 
RNA [16]. For SINV, such a system is active in de novo RNA synthesis, indicating that RC assembly 
is achievable in vitro if the template RNA is provided before nsP4 has associated with the 
polyprotein P123. 
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